Sign in
Not yet taking people in United StatesNo phase

Studies whether sleep apnea links to a type of glaucoma

Observes people with sleep apnea and normal tension glaucoma through eye and sleep tests.

Key facts

Who runs it
Northwell Health
Where
New York, United StatesSee the site
Trial code
Registry title
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Status
Not yet recruiting
People taking part
100 people, planned
Started
2 Sept 2025
Expected to end
1 Sept 2028
Type of study
Observational, 3 groups
Treatments tested
  • Clinical observation, diagnostic testing
Record updated
10 June 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who were newly diagnosed with obstructive sleep apnea and will start CPAP treatment. It studies the link between sleep apnea and normal tension glaucoma.

Age
At least 21 years old.
Sex
All sexes can join.
Disease stage
Newly diagnosed obstructive sleep apnea (OSA).
Earlier treatment
People must be about to start CPAP treatment for sleep apnea. People with a history of severe eye trauma, eye inflammation or eye surgery cannot join, except uncomplicated cataract surgery with a lens implant.

Main reasons for not taking part

  • Narrow angle glaucoma
  • High glasses prescription: over ±6.0 diopters, or cylinder over -3.0 D
  • History of severe eye trauma, eye inflammation or eye surgery (except uncomplicated cataract surgery with lens implant)
  • Diabetic retinopathy or other retinal changes that prevent a reliable check of the optic disc
  • Allergy to any component of altafluor benox

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Newly diagnosed subjects with OSA that will undergo CPAP treatment
  • At least 21 years of age
  • Best corrected vision of 20/40 or better, spherical Rx < ± 6.0 Diopter, and cylinder <-3.0D
  • Ability to follow instructions, and intent to complete all study visits

Who cannot take part

  • History of any of the following: severe eye trauma, ocular inflammation, previous intraocular surgery except for uncomplicated cataract extraction with posterior chamber intraocular lens implantation
  • Any medical or ocular condition which is not appropriate for participation in the trial (Diabetic retinopathy, and other retinal changes preventing reliable optic disc evaluation) Hypersensitivity to any component of altafluor benox
  • High Rx >± 6.0D and cylinder > -3.0D
  • Narrow angle glaucoma

Where in United States

  • Manhattan Eye, Ear & Throat HospitalNew York, United StatesContact: Andrew Tirsi, MDNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this research study is to learn more about the relationship between Obstructive Sleep Apnea (OSA) and Normal Tension Glaucoma (NTG). OSA is a nighttime disorder of the upper airway that causes an intermittent lack of oxygen while sleeping. NTG is a type of glaucoma that occurs despite the normal intraocular pressure levels, making its detection more difficult. Left untreated, irreversible optic nerve damage and extensive vision loss can result. Previous research has shown some evidence between OSA and the development of NTG. The investigators are researching whether undergoing treatment for OSA would help to improve the vascular health to the retina, and in effect, improve the early signs of visual dysfunction seen with diagnostic testing.

The 3 groups in the trial

  • Newly-diagnosed mild OSA - initiating CPAP treatment

    Subjects with newly-diagnosed mild obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.

    Treatment: Clinical observation, diagnostic testing

  • Newly-diagnosed moderate OSA - initiating CPAP treatment

    Subjects with newly-diagnosed moderate obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.

    Treatment: Clinical observation, diagnostic testing

  • Newly-diagnosed severe OSA - initiating CPAP treatment

    Subjects with newly-diagnosed severe obstructive sleep apnea being treated with CPAP undergoing clinical observation/diagnostic evaluation for detection and tracking of NTG.

    Treatment: Clinical observation, diagnostic testing

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness
Plain-language title
Studies whether sleep apnea links to a type of glaucomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 June 2025